(DUK) Duke Energy - Overview
Stock: Electricity, Natural Gas, Renewable Energy, Transmission
| Risk 5d forecast | |
|---|---|
| Volatility | 17.1% |
| Relative Tail Risk | 1.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 11.65 |
| Character TTM | |
|---|---|
| Beta | -0.062 |
| Beta Downside | -0.002 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.48% |
| CAGR/Max DD | 1.06 |
EPS (Earnings per Share)
Revenue
Description: DUK Duke Energy January 28, 2026
Duke Energy Corp. (NYSE:DUK) operates two regulated segments in the United States: Electric Utilities & Infrastructure (EU&I), serving about 8.6 million electricity customers across the Southeast and Midwest, and Gas Utilities & Infrastructure (GU&I), delivering natural gas to roughly 1.7 million customers. The EU&I business generates power from a diversified mix-including coal, natural gas, nuclear, hydro, and expanding renewable assets-while also wholesaling electricity to municipalities and cooperatives. The GU&I segment focuses on gas distribution, pipeline transmission projects, renewable natural gas (RNG) development, and underground storage.
Key recent metrics (FY 2023): revenue $30.7 bn, net income $2.9 bn, and a regulated return on equity of ~9.5 % in the electric segment. Capital expenditures rose 12 % YoY to $5.2 bn, driven largely by renewable-energy and grid-modernization projects. The company’s debt-to-EBITDA ratio stands at 4.2×, reflecting a balance-sheet profile typical for capital-intensive utilities. Sector-wide, U.S. electricity demand is projected to grow ~1.5 % annually through 2028, while natural-gas consumption is expected to be volatile due to shifting fuel-mix preferences and ESG-related regulatory pressure.
For a deeper, data-rich analysis of DUK’s valuation dynamics, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 4.96b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 4.40 > 1.0 |
| NWC/Revenue: -29.15% < 20% (prev -21.11%; Δ -8.04% < -1%) |
| CFO/TA 0.11 > 3% & CFO 21.00b > Net Income 4.96b |
| Net Debt (90.62b) to EBITDA (15.67b): 5.78 < 3 |
| Current Ratio: 0.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (777.0m) vs 12m ago 0.52% < -2% |
| Gross Margin: 54.04% > 18% (prev 0.50%; Δ 5354 % > 0.5%) |
| Asset Turnover: 16.94% > 50% (prev 16.29%; Δ 0.65% > 0%) |
| Interest Coverage Ratio: 2.57 > 6 (EBITDA TTM 15.67b / Interest Expense TTM 3.63b) |
Altman Z'' 0.14
| A: -0.05 (Total Current Assets 11.61b - Total Current Liabilities 21.05b) / Total Assets 195.74b |
| B: 0.03 (Retained Earnings 5.06b / Total Assets 195.74b) |
| C: 0.05 (EBIT TTM 9.35b / Avg Total Assets 191.04b) |
| D: 0.04 (Book Value of Equity 5.25b / Total Liabilities 142.72b) |
| Altman-Z'' Score: 0.14 = B |
Beneish M -3.24
| DSRI: 0.85 (Receivables 4.21b/4.67b, Revenue 32.36b/30.36b) |
| GMI: 0.93 (GM 54.04% / 50.06%) |
| AQI: 1.03 (AQ_t 0.27 / AQ_t-1 0.26) |
| SGI: 1.07 (Revenue 32.36b / 30.36b) |
| TATA: -0.08 (NI 4.96b - CFO 21.00b) / TA 195.74b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of DUK shares?
Over the past week, the price has changed by +6.10%, over one month by +10.14%, over three months by +5.52% and over the past year by +17.57%.
Is DUK a buy, sell or hold?
- StrongBuy: 7
- Buy: 2
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 134.4 | 4.8% |
| Analysts Target Price | 134.4 | 4.8% |
| ValueRay Target Price | 145.2 | 13.3% |
DUK Fundamental Data Overview February 14, 2026
P/E Forward = 18.6916
P/S = 3.0422
P/B = 1.914
P/EG = 2.3957
Revenue TTM = 32.36b USD
EBIT TTM = 9.35b USD
EBITDA TTM = 15.67b USD
Long Term Debt = 80.11b USD (from longTermDebt, last quarter)
Short Term Debt = 9.73b USD (from shortTermDebt, last quarter)
Debt = 90.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 90.62b USD (from netDebt column, last quarter)
Enterprise Value = 188.69b USD (98.07b + Debt 90.87b - CCE 245.0m)
Interest Coverage Ratio = 2.57 (Ebit TTM 9.35b / Interest Expense TTM 3.63b)
EV/FCF = 21.76x (Enterprise Value 188.69b / FCF TTM 8.67b)
FCF Yield = 4.60% (FCF TTM 8.67b / Enterprise Value 188.69b)
FCF Margin = 26.80% (FCF TTM 8.67b / Revenue TTM 32.36b)
Net Margin = 15.34% (Net Income TTM 4.96b / Revenue TTM 32.36b)
Gross Margin = 54.04% ((Revenue TTM 32.36b - Cost of Revenue TTM 14.87b) / Revenue TTM)
Gross Margin QoQ = 30.49% (prev none%)
Tobins Q-Ratio = 0.96 (Enterprise Value 188.69b / Total Assets 195.74b)
Interest Expense / Debt = 1.04% (Interest Expense 946.0m / Debt 90.87b)
Taxrate = 11.34% (154.0m / 1.36b)
NOPAT = 8.29b (EBIT 9.35b * (1 - 11.34%))
Current Ratio = 0.55 (Total Current Assets 11.61b / Total Current Liabilities 21.05b)
Debt / Equity = 1.75 (Debt 90.87b / totalStockholderEquity, last quarter 51.84b)
Debt / EBITDA = 5.78 (Net Debt 90.62b / EBITDA 15.67b)
Debt / FCF = 10.45 (Net Debt 90.62b / FCF TTM 8.67b)
Total Stockholder Equity = 51.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.60% (Net Income 4.96b / Total Assets 195.74b)
RoE = 9.69% (Net Income TTM 4.96b / Total Stockholder Equity 51.22b)
RoCE = 7.12% (EBIT 9.35b / Capital Employed (Equity 51.22b + L.T.Debt 80.11b))
RoIC = 6.02% (NOPAT 8.29b / Invested Capital 137.54b)
WACC = 3.40% (E(98.07b)/V(188.94b) * Re(5.69%) + D(90.87b)/V(188.94b) * Rd(1.04%) * (1-Tc(0.11)))
Discount Rate = 5.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈5.22b ; Y1≈3.43b ; Y5≈1.56b
Fair Price DCF = N/A (negative equity: EV 49.84b - Net Debt 90.62b = -40.78b; debt exceeds intrinsic value)
EPS Correlation: 39.13 | EPS CAGR: 3.89% | SUE: 0.11 | # QB: 0
Revenue Correlation: 57.75 | Revenue CAGR: 2.90% | SUE: 1.15 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.71 | Chg30d=+0.005 | Revisions Net=-3 | Analysts=11
EPS current Year (2026-12-31): EPS=6.70 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=+6.2% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=7.15 | Chg30d=-0.018 | Revisions Net=-2 | Growth EPS=+6.7% | Growth Revenue=+4.3%